中国广西石灰岩地区苦苣苔科一新种——鹿寨唇柱苣苔

描述了中国广西石灰岩地区苦苣苔科(Gesneriaceae)1新种--鹿寨唇柱苣苔(Chirita luzhaiensis Yah Lin,Y.S.Huang & W.B.Xu).该种与桂林唇柱苣苔(Chirita gueilinensis W.T.Wang)相似,但叶面被长柔毛和短柔毛,花药无毛,花丝近基部膝状弯曲,退化雄蕊3枚,无毛,花期12月至次年1月可与后者区别.目前,鹿寨唇柱苣苔仅见于广西鹿寨县中渡镇的两个石灰岩山洞中.     

钻形紫菀开花期种群构件的生物量分配

在野外用样方法,选取60株钻形紫菀(Aster subulatus Michx.)开花植株,进行根、茎、叶及花等构件的生物量及其物质分配关系的研究.结果表明:钻形紫菀开花期构件生物量为茎>花>根>叶,其变异系数分别为57.15%、64.66%、57.65%和55.2%,具有较大表型可塑性;在各构件物质分配变异系数中,花生物量分配的变异系数相对较大,说明其调节生殖分配的能力较强;植株高度与各构件生物量呈显著的正相关性,随着各构件生物量的增加均呈幂函数形式增加;花生物量分配与总生物量呈显著的正相关性,其余构件生物量分配均与总生物量及花生物量分配呈负相关性,物质分配由营养构件、支持构件、光合构件向生殖构件转移.反映出钻形紫菀具有自我调节生长力的分配策略,对异质环境具有较强适应能力.     

蜈蚣草是观察减数分裂过程的好材料

以蜈蚣草（Pteris vittata Linn.）为材料,介绍了蜈蚣草孢子母细胞减数分裂的制作方法。该方法操作简单、成功率高;主要特点是在同一孢子囊群中,孢子母细胞的减数分裂不同步,可以同时观察到前期到末期Ⅱ之间各个时期的分裂相。蜈蚣草分布广、取材容易,是观察减数分裂过程的一种好材料。     

Syntheses, structures and properties of copper(II) and cobalt(II) metal-organic frameworks based on R-isophthalate (R = -CH3 or -C(CH3)3) and 1,1′-(1,4-butanediyl)bis(imidazole) ligands

Three new complexes [Cu₂(mip)₂(bbi)]_n (1), {[Cu₂(tbip)₂(bbi)₂(H₂O)]·2H₂O}_n (2) and {[Co₂(tbip)₂(bbi)₂]·2H₂O}_n (3), were prepared through hydrothermal reactions of Cu(II) and Co(II) acetate with H₂mip or H₂tbip (H₂mip = 5-methyl isophthalic acid and H₂tbip = 5-tert-butyl isophthalic acid) and the flexible ligand bbi (bbi = 1,1′-(1,4-butanediyl)bis(imidazole)). All these complexes were structurally characterized by elemental analysis, IR spectroscopy and X-ray single-crystal diffraction. Complex 1 exhibits a 3D network, which are constructed from 2D carboxylate layer and bbi pillar. Complex 2 possesses a 2D layer structure, and exists extensive hydrogen-bonding interactions, while complex 3 is constructed from 2D layers which consists of alternating left- and right-handed helical chains, and further assembled to form a 3D framework by hydrogen-bonding interactions. The thermal stabilities of the corresponding complexes have been briefly investigated. In addition, dominant antiferromagnetic coupling was observed in complex 1.     

Efficacy of plant extracts against stored-products fungi

The fungistatic activity of six aqueous extracts of plants were tested against Aspergillus candidus, Aspergillus niger, Penicillium sp. and Fusarium culmorum. The plants were, chamomile (Anthemis nobilis L.), cinnamon (Cinnamomum verum J. Presl.), French lavender (Lavandula stoechas L.), garlic (Allium sativum L.), malva (Malva sylvestris L.) and peppermint (Mentha piperita L.). The more concentrated extracts of chamomile and malva inhibited totally the growth of the tested fungi with malva the most effective one.     

松科冷杉属植物的化石历史和现代分布

冷杉是北半球阴暗针叶林的优势种和建群种,现全世界共有52种1亚种12变种,在北半球形成南欧、北美和东亚三个分布中心,这三个地区也是冷杉属化石最丰富的地区。在垂直分布上,冷杉集中分布于1000～2000m（15种）和2500～4000m（13种）两个海拔地段。在中国,冷杉植物呈南北间断分布,集中分布在横断山地区。冷杉属的特有现象和孑遗分布现象都十分突出,有7个种呈孑遗分布。根据冷杉属的地史分布和现代分布的研究并结合最新的系统演化资料,本文推测冷杉属于白垩世中期起源于北半球的中高纬度地区,始新世以后,随着全球气候的变冷,逐步向南迁移,由于喜马拉雅山脉、阿尔卑斯山、落基山脉抬升及东亚季风气候的出现以及第四纪冰期的影响而形成了现代间断的分布格局。冷杉与银杉、金钱松等其它松科植物的形成模式十分相似。     

广东罗坑自然保护区鳄蜥夏季生境特征

2005年6—8月,在广东省罗坑自然保护区对36处鳄蜥的生境特征进行了研究。采用样线调查法,在保护区内鳄蜥分布区随机选取了30条溪沟进行调查,对每处有鳄蜥分布的生境测量了15个相关的生态因子。通过主成分分析发现,回水塘长度和宽度、水源距离、水流速度、栖枝高度、栖枝直径、干扰距离、植被类型、植被盖度等9个生态因子对鳄蜥的生境选择有显著影响,而回水塘底质组成、回水塘水深、栖枝枯活状况、栖枝角度、溪沟类型和溪沟坡向6个生态因子的影响不显著。鳄蜥偏好的生境可归结为回水塘长度、宽度中等(均为1.0—2.0m),有位于水源正上方的栖枝,水流速度缓慢,栖枝高度0.5—1.0m、栖枝直径≤1.00cm,干扰距离>500m,植被类型为常绿阔叶林、植被盖度>60%的生境。建议提高当地居民的保护意识,重点保护水源林和溪沟两侧的植被。     

GFP示踪观察移植瘤原代培养细胞的生长规律

采用GFP稳定表达的细胞系(293-BAC)接种裸鼠形成移植瘤.取肿瘤组织进行原代培养,通过GFP示踪和细胞形态学变化,观察了肿瘤组织中细胞的生长规律.肿瘤细胞释放并生长在组织块附近,向周围空间延伸.种植时散落的薄层组织细胞则直接贴壁生长.生长的鼠源间质细胞占总细胞量的1%～3%,散在或在组织新生肿瘤细胞外围集中生长.原代培养的细胞在传代5代以后,其中的鼠源细胞消失.经过成瘤和传代过程的肿瘤细胞生长性能稳定、来源纯净,是相关研究的好材料.观察到的细胞生长规律可为移植瘤的相关研究提供参考.     

DNMT3A rs36012910 A>G polymorphism and gastric cancer susceptibility in a Chinese population

DNA-methyltransferase (DNMT)-3A plays a crucial role in embryonic development and aberrant DNA methylation in carcinogenesis. Polymorphisms of the DNMT3A gene may influence its enzymatic activity and its contribution to susceptibility to cancer. This study evaluated the association of DNMT3A rs36012910 A>G with susceptibility to gastric cancer (GC) in a Chinese population. Genomic DNA was extracted from samples taken from 340 patients with GC and 251 healthy control subjects. The genotype frequency of DNMT3A rs36012910 A>G in all subjects was detected by polymerase chain reaction–restriction fragment length polymorphism and confirmed by sequencing. Stratification analyses were used to study subgroups by age and gender and to evaluate the association of rs36012910 A>G polymorphism with genetic susceptibility to GC. All patients and control individuals were successfully genotyped for the DNMT3A rs36012910 A>G polymorphism. The frequency of DNMT3A rs36012910 allele G is 3.39?% in healthy individuals and 7.78?% in GC patients, respectively. The rs36012910 AG genotype was significantly more common in the GC group than in the controls, although the rs36012910 GG genotype was only one case in GC patients. Further stratification indicated that AG+GG genotypes were associated with susceptibility to GC in males older than 60, but this polymorphism has no significant association with GC susceptibility in females. Male individuals who carried AG+GG genotypes had a 2.362-fold increased risk of GC compared to those who carried the AA genotype. The rs36012910 allele G was associated with an increased risk of GC compared to the rs36012910 allele A. This is the first report to investigate the distribution and evaluate the association of a rare SNP in DNMT3A with genetic susceptibility to GC. DNMT3A rs36012910 A>G might become a potential biomarker for use in GC prediction, although further studies in larger groups and different populations are needed for confirmation.     

Synergistic inhibitory effects by the combination of gefitinib and genistein on NSCLC with acquired drug-resistance in vitro and in vivo

In clinical practice, most patients with non small cell lung cancer (NSCLC) who respond to tyrosine kinase inhibitors eventually progress because of an acquired resistance mutation, T790M, in epidermal growth factor receptor (EGFR). Thus, it is important to identify a new drug to reduce resistance. The aim of this study was to test whether genistein combined with gefitinib is effective against NSCLC in a cell line carrying T790M, and to clarify the underlying mechanisms. The human lung cancer cell line H1975 was used as an in vitro and in vivo model. Cells were treated with gefitinib, genistein, or a combination at a range of concentrations. Cell proliferation was calculated to assess the anticancer effects of the compounds in vitro. Flow cytometry and Western blotting were employed to determine the inhibitory effects on proliferation and the induction of apoptosis. The in vivo effects of the compounds were examined using a xenografted nude mouse model for validation. Gefitinib together with genistein enhanced both growth inhibition and apoptosis; however, the greatest synergistic effect was observed at low concentrations. p-EGFR, p-Akt, and p-mTOR expressions in vitro were reduced more by the combined use of the drugs, whereas caspase-3 and PARP activities were increased. Significantly more tumor growth inhibition was detected following combination treatment in the in vivo model. These findings suggest that genistein enhanced the antitumor effects of gefitinib in a NSCLC cell line carrying the T790M mutation. This synergistic activity may be due to increased inhibition of the downstream molecular and pro-apoptotic effects of EGFR.